| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.6 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |